Tenofovir vs. Entecavir after treatment for HBV-associated HCC

Published Date: 08 Mar 2023

This review compared the effectiveness of entecavir and tenofovir in reducing relapses and mortality after treatment for HBV-related hepatocellular carcinoma.

Read Full News

Latest News

US CDC Deploys Staff to Curb South Carolina's Measles Outbreak

(Refiles to remove extraneous word years from first paragraph)

After FDA Declined Review, EMA Backs 1st Flu-COVID mRNA Vax

The Moderna vaccine will likely be available in Europe long before the US.

Peak Anti-HBs Level May Predict Protection in HIV Infection

Peak anti-hepatitis B surface antibody levels predicted increased viral protection in HIV, a French study shows.

Doravirine Plus Islatravir Matches Standard HIV Therapy

In patients with HIV‑1 infection and virologic suppression, switching to an investigational regimen of doravirine plus islatravir shows efficacy and safety similar to standard ART regimens.

European Guidance Advances Cardiovascular Risk Assessment

The 2025 update integrates new risk estimation tools and shifts acute coronary syndrome management toward earlier intensive lipid-lowering therapy.

Exclusive-US Postpones Third Consecutive Meeting Of Preventive Health Panel

The March meeting of the U.S. advisory panel that determines what cancer screenings and other preventive health measures insurers must cover has been postponed, according to...

Todays Updates

Biomarker Flags 10-Fold Recurrence Risk in Testicular Cancer

MiR-371 isn’t ready for the clinic yet, but it is ready for interventional trials to see if it can refine adjuvant chemotherapy decisions in stage I testicular cancer.

FDA Approves New Drug Combo for RR Multiple Myeloma

Teclistamab plus daratumumab and hyaluronidase-fihj is approved for relapsed or refractory MM after one prior line of therapy, including a proteasome inhibitor and immunomodulatory agent.

Todays Updates

Biomarker Flags 10-Fold Recurrence Risk in Testicular Cancer

MiR-371 isn’t ready for the clinic yet, but it is ready for interventional trials to see if it can refine adjuvant chemotherapy decisions in stage I testicular cancer.

FDA Approves New Drug Combo for RR Multiple Myeloma

Teclistamab plus daratumumab and hyaluronidase-fihj is approved for relapsed or refractory MM after one prior line of therapy, including a proteasome inhibitor and immunomodulatory agent.

Latest News

(Refiles to remove extraneous word years from first paragraph)

The Moderna vaccine will likely be available in Europe long before the US.

Peak anti-hepatitis B surface antibody levels predicted increased viral protection in HIV, a French study shows.

In patients with HIV‑1 infection and virologic suppression, switching to an investigational regimen of doravirine plus islatravir shows efficacy and safety similar to standard ART regimens.

The 2025 update integrates new risk estimation tools and shifts acute coronary syndrome management toward earlier intensive lipid-lowering therapy.

The March meeting of the U.S. advisory panel that determines what cancer screenings and other preventive health measures insurers must cover has been postponed, according to...

News All Time

Response to RSV Varies With Age

Tissue modeling outlines how respiratory syncytial virus promotes different disease outcomes in children and adults.

US CDC Vaccine Panel to Meet in March After February Session Scrapped

The U.S. Centers for Disease Control and Prevention's vaccine advisory committee is set to meet on March ⁠18 to 19, an update on the agency's website showed on Tuesday,...

Zimbabwe Ends $367 Million Health Funding Talks With US

Zimbabwe has pulled out of talks on a $367 million bilateral health agreement with the US due to concerns over sharing sensitive health data in return for financial support.

Long-Acting HIV Drug Switch Shows No Major Metabolic Impact

In patients with HIV infection, a switch to long acting cabotegravir plus rilpivirine shows no clinically meaningful changes in body composition or adverse metabolic effects over 48 weeks.

Mobile Telemedicine Boosts Rural Access to HCV Treatment

Among rural people with chronic HCV infection and a history of injection drug use, a mobile telemedicine-based intervention vs enhanced usual care improves treatment initiation and cure rates.

RSV Vaccine in Multidose Vial Matches Single-Dose Vial

In healthy, nonpregnant women, the multidose vial of RSVpreF vaccine produces immune responses and safety outcomes comparable to the single-dose vial, a trial finds.

US FDA Reverses Course, Will Review Moderna's Flu Vaccine Application

Moderna said on Wednesday the U.S. Food and Drug Administration changed course and will review an amended application for its new flu vaccine, a week after rejecting the...

AAP Finds No New Evidence Against Hep B Vaccine Birth Dose

AAP publishes review of safety and efficacy of hepatitis B vaccination birth dose.

Healthy Life Expectancy Declines Again

Years spent in good health have dropped to their lowest level since comparable data were first collected in 2011 to 2013, with stark regional gaps across the UK.

Long-Acting HIV Therapy May Be Safe After HBV Exposure

Switching to a long-acting cabotegravir/rilpivirine antiretroviral regimen may be safe for patients with HIV who have prior hepatitis B virus exposure, a real-world study shows.

Next-Day HIV Test Result Show Mixed Effects on Seeking Care

Next-day HIV viral load test results do not improve overall linkage to care when added to standard testing but are tied to faster linkage to antiretroviral therapy among people with HIV infection.

ED Screening Uncovers Elevated Risk for Cervical Cancer

Emergency department-based cervical cancer interventions identify precancerous lesions and high-risk human papillomavirus at rates higher than the national average, a study shows.

Cancer Screening Gaps Leave People With HIV at Elevated Risk

International guidelines recommend anal and liver surveillance for people with HIV, but Brazil lacks a national protocol; clinicians should integrate screening and vaccination.

STI Prevention With Doxycycline Raises Resistance Fears

Public health authorities warn clinicians to weigh risks and enroll patients in supervised programs: routine testing, partner management, and resistance surveillance are essential.

Pritelivir Shows Promise for HSV

The new oral therapy demonstrates superior lesion healing for complex patients who have few current treatment options.

Gaps in Primary Care Affect Transgender Health in Spain

Data from more than 1800 participants outlines structural barriers, high mental health diagnoses, and uneven access to gender-affirming and preventive services.

Recommended News For You

Omicron Infections Are Usually Cleared Up in Immunocompromised Patients.

A First in Total Larynx Transplant; 'Sniffing' Out Lung Cancer; Gen X Cancer Toll

Heavy Cannabis Use Tied to Increased Head and Neck Cancer Risk

Did U.S. Government Play a Role in Remote Tribe's Widespread Illness and Cancer?

After two years, a significant left nasal obstruction was finally diagnosed.

Single-dose radiation before surgery can eradicate breast cancer

Research Indicates that First-Line Immunotherapy Is Enough for Elderly NSCLC Patients?

Recommended Articles For You

A Breakthrough in Multiple Myeloma: Darzalex Delays Disease Progression by 51% 

Revolutionizing Cancer Treatment with Darzalex: How an Innovative Drug is Transforming Lives 

Tailoring the Immune Response: The Dawn of Personalized Vaccines in Cancer Immunotherapy 

Beyond the Organs: Navigating the Era of Tissue-Agnostic Therapies in Modern Cancer Management 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Healthcare in the Mix in President Biden's Farewell Address

2.

Using MRD Status to Deescalate Multiple Myeloma Therapy

3.

In patients with advanced lung cancer, cemiplimab combined with chemotherapy extends life and enhances quality of life.

4.

PET-CT finds further-reaching metastases in patients with locally advanced breast cancer.

5.

Additional Proof of the Different Cognitive Effects of ARSIs for Prostate Cancer.

1.

Oncolytic Adenoviruses Targeting PD-L1: Advancing Cancer Immunotherapy and Tumor Control

2.

Unlocking the Power of Neutrophils: Harnessing Their Disease-Fighting Potential

3.

Nuclear Medicine's Role in Battling Women's Cancers

4.

Precision Medicine and Genomics: Harnessing Longitudinal Data Modeling to Decode Cancer Progression

5.

Fresh Frozen Plasma: Its Role in Treating Trauma and Bleeding Disorders

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Role of Nimotuzumab in Management of Nasopharyngeal Cancer

2.

Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals

3.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV

4.

Navigating the Complexities of Ph Negative ALL - Part XVI

5.

Optimizing Treatment Options in Advanced Urothelial Carcinoma

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot